Evan Loh's Net Worth
$2.23 Million
Who is Evan Loh?
Evan Loh has an estimated net worth of $2.23 Million. This is based on reported shares across multiple companies, which include Nivalis Therapeutics, Inc., Eiger BioPharmaceuticals, Inc., WINDTREE THERAPEUTICS INC /DE/, and Paratek Pharmaceuticals, Inc..
SEC CIK
Evan Loh's CIK is 0001622680
Past Insider Trading and Trends
2015 was Evan Loh's most active year for acquiring shares with 8 total transactions. Evan Loh's most active month to acquire stocks was the month of February. 2017 was Evan Loh's most active year for disposing of shares, totalling 8 transactions. Evan Loh's most active month to dispose stocks was the month of November. 2020 saw Evan Loh paying a total of $169,759.70 for 273,479 shares, this is the most they've acquired in one year. In 2021 Evan Loh cashed out on 159,661 shares for a total of $925,845.89, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Nivalis Therapeutics, Inc. (ALPN) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Eiger BioPharmaceuticals, Inc. (EIGR) No price found
InvestorEvan Loh owns 14,000 units of Common Stock. In the year 2017 Evan Loh filed a total of 8 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
| +75.00% | 6K |
—
|
—
| 14K |
Mar 11
| |||
Form 4
| +60.00% | 3K |
$10.14 | -$20,280.00 | 8K |
Mar 12 - Mar 15
| |||
Form 4
|
∞
| 5K |
—
|
—
| 5K |
Mar 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
WINDTREE THERAPEUTICS INC /DE/ (WINT) Snapshot price: $2.79
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Paratek Pharmaceuticals, Inc. No price found
CEOEvan Loh used to own units in Common Stock but no longer holds any shares there. In the year 2014 Evan Loh filed a total of 41 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.33M |
—
|
—
|
0
|
Sep 21
| |||
Form 4
| +9.91% | 119.78K |
$2.20 | -$107,727.40 | 1.33M |
Aug 8 - Aug 9
| |||
Form 4
| +2.46% | 29.01K |
$1.99 | -$46,743.11 | 1.21M |
Scheduled
|
Dec 20 - Dec 21
| ||
Form 4
| -7.80% | -99.75K |
$1.97 | -$196,266.62 | 1.18M |
Scheduled
|
Dec 12 - Dec 13
| ||
Form 4
| -0.68% | -8.80K |
$3.47 | -$30,553.35 | 1.28M |
Scheduled
|
Oct 28
| ||
Form 4
| +2.39% | 30K |
—
|
—
| 1.29M |
Oct 25
| |||
Form 4
| +9.41% | 108.21K |
$2.66 | -$118,420.54 | 1.26M |
Scheduled
|
Aug 8 - Aug 9
| ||
Form 4
| +25.87% | 236.25K |
—
|
—
| 1.15M |
Mar 15
| |||
Form 4
| -8.70% | -87.08K |
$4.32 | -$376,295.37 | 913.28K |
Scheduled
|
Dec 13 - Dec 15
| ||
Form 4
| +4.28% | 41.07K |
$5.12 | -$173,726.72 | 1M |
Scheduled
|
Aug 16 - Aug 17
| ||
Form 4
| +6.08% | 54.98K |
$9.70 | -$355,543.80 | 959.29K |
Scheduled
|
May 27 - Jun 4
| ||
Form 4
| +50.58% | 303.75K |
—
|
—
| 904.31K |
Mar 30
| |||
Form 4
| -6.97% | -45.00K |
$6.81 | -$306,410.40 | 600.56K |
Scheduled
|
Dec 11 - Dec 14
| ||
Form 4
| +9.14% | 54.07K |
$5.93 | -$124,103.04 | 645.56K |
Scheduled
|
Nov 12 - Nov 13
| ||
Form 4
| +7.15% | 39.48K |
$4.30 | $169,759.70 | 591.49K |
Oct 29
| |||
Form 4
| -1.71% | -9.60K |
$4.75 | -$45,576.25 | 552.01K |
May 12
| |||
Form 4
| +34.48% | 144K |
—
|
—
| 561.6K |
Feb 19
| |||
Form 4
| -3.36% | -14.51K |
$3.10 | -$44,993.40 | 417.6K |
Dec 12
| |||
Form 4
| +4.39% | 18.18K |
$3.82 | -$29,864.76 | 432.12K |
Scheduled
|
Oct 4 - Oct 8
| ||
Form 4
| -3.78% | -16.27K |
$3.98 | -$64,734.70 | 413.94K |
Scheduled
|
Oct 3
| ||
Form 4
| +38.68% | 120K |
—
|
—
| 430.2K |
Feb 26
| |||
Form 4
| +11.70% | 32.5K |
—
|
—
| 310.2K |
Feb 1
| |||
Form 4
| -3.98% | -11.53K |
$6.50 | -$74,969.00 | 277.7K |
Scheduled
|
Dec 12 - Dec 13
| ||
Form 4
| +2.77% | 7.8K |
$8.96 | -$46,592.00 | 289.23K |
Scheduled
|
Oct 12 - Oct 15
| ||
Form 4
| +38.78% | 78.64K |
$9.82 | -$87,015.02 | 281.43K |
Scheduled
|
Oct 2 - Oct 3
| ||
Form 4
| -5.59% | -12.00K |
$9.97 | -$119,640.00 | 202.79K |
Scheduled
|
Jul 2
| ||
Form 4
| -3.63% | -8.08K |
$12.70 | -$102,666.80 | 214.79K |
Scheduled
|
Apr 9
| ||
Form 4
| +9.59% | 19.5K |
—
|
—
| 222.87K |
Apr 3
| |||
Form 4
| +40.38% | 58.5K |
—
|
—
| 203.37K |
Feb 14
| |||
Form 4
| -2.06% | -3.04K |
$14.22 | -$43,228.80 | 144.87K |
Scheduled
|
Feb 5
| ||
Form 4
| +36.41% | 39.48K |
$4.30 | $169,755.40 | 147.91K |
Jul 19
| |||
Form 4
| +8.67% | 8.65K |
$23.58 | -$102,591.36 | 108.43K |
Scheduled
|
Jul 3 - Jul 5
| ||
Form 4
| -3.02% | -3.11K |
$15.09 | -$46,880.88 | 99.78K |
Scheduled
|
Feb 6
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
| +27.99% | 22.5K |
—
|
—
| 102.89K |
Feb 4
| |||
Form 4
| +2.95% | 2.3K |
$16.87 | $38,803.00 | 80.39K |
Dec 10 - Dec 11
| |||
Form 4
| +4.97% | 3.7K |
$16.16 | $59,792.00 | 78.09K |
Nov 16
| |||
Form 4
| +67.58% | 30K |
—
|
—
| 74.39K |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
|
∞
| 44.39K |
—
|
—
| 44.39K |
Oct 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |